Pharma major Dr Reddy’s Laboratories has recalled some lots of Lansoprazole, a drug for the treatment of heart-burn.
According to the US Food and Drug Administration, the Hyderabad-based company was recalling 58,656 bottles of the drug due to a microbial contamination.
The recall has been classified as ‘Class II’, which, as per FDA norms, is not a serious problem, with only a remote chance of severe adverse consequences from contamination in the product.
A Dr Reddy’s spokesperson said that it was a voluntary recall and that there was no financial implication.
On the Bombay Stock Exchange, the Dr Reddy’s scrip ended Thursday at ₹2,734, up 1.63 per cent.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.